Defining the mechanisms of action and resistance to the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain models https://www.biorxiv.org/content/10.1101/2023.04.14.536907v1?med=mas
Defining the mechanisms of action and resistance to the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain models https://www.biorxiv.org/content/10.1101/2023.04.14.536907v1?med=mas